Flow Pharma Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $225K

  • Investors
  • 9

Flow Pharma General Information

Description

Developer of an immunotherapy platform designed to offer curative intervention in cancer and viral disease. The company's platform uses artificial intelligence to create, detect, synthesize, and deliver identical peptides to stimulate therapeutic attacks by the patient's native immune system, enabling patients to have medicines that treat and prevent disease via selective T-cell stimulation.

Contact Information

Website
flowpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4829 Galaxy Parkway
  • Suite K, Warrensville Heights
  • Cleveland, OH 44128
  • United States
+1 (216)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • 4829 Galaxy Parkway
  • Suite K, Warrensville Heights
  • Cleveland, OH 44128
  • United States
+1 (216)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Flow Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 01-Aug-2024 $225K Completed Clinical Trials - General
8. Later Stage VC (Series B) 02-Nov-2022 Completed Clinical Trials - General
7. Later Stage VC (Series A) 01-Dec-2021 Completed Clinical Trials - General
6. Accelerator/Incubator 01-Jan-2021 Completed Clinical Trials - General
5. Debt - PPP 14-Apr-2020 Completed Clinical Trials - General
4. Grant 01-Jan-2020 Completed Clinical Trials - General
3. Seed Round 28-Feb-2018 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Angel (individual) 01-May-1999 Completed Startup
To view Flow Pharma’s complete valuation and funding history, request access »

Flow Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Flow Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Flow Pharma Patents

Flow Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3216277-A1 Microsphere formulations comprising multiple non-identical peptides and methods for making the same Pending 23-Apr-2021
EP-4326237-A2 Microsphere formulations comprising multiple non-identical peptides and methods for making the same Pending 23-Apr-2021
EP-4326237-A4 Microsphere formulations comprising multiple non-identical peptides and methods for making the same Pending 23-Apr-2021
US-20250268836-A1 Microsphere formulations comprising multiple non-identical peptides and methods for making the same Pending 23-Apr-2021
CA-3216268-A1 Vaccine for sars-cov-2 Pending 23-Apr-2021 A61K39/00115
To view Flow Pharma’s complete patent history, request access »

Flow Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Flow Pharma Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
P4 Precision Accelerator/Incubator
Small Business Innovation Research and Small Business Technology Transfer Programs Government
United States Department of War Government
Button Capital Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 9 investors. Get the full list »

Flow Pharma Investments (1)

Flow Pharma’s most recent deal was a Joint Venture with Strategic Vaccines.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Strategic Vaccines Joint Venture Pharmaceuticals
To view Flow Pharma’s complete investments history, request access »

Flow Pharma FAQs

  • When was Flow Pharma founded?

    Flow Pharma was founded in 1999.

  • Where is Flow Pharma headquartered?

    Flow Pharma is headquartered in Cleveland, OH.

  • What is the size of Flow Pharma?

    Flow Pharma has 5 total employees.

  • What industry is Flow Pharma in?

    Flow Pharma’s primary industry is Drug Discovery.

  • Is Flow Pharma a private or public company?

    Flow Pharma is a Private company.

  • What is Flow Pharma’s current revenue?

    The current revenue for Flow Pharma is .

  • How much funding has Flow Pharma raised over time?

    Flow Pharma has raised $38.6M.

  • Who are Flow Pharma’s investors?

    P4 Precision, Small Business Innovation Research and Small Business Technology Transfer Programs, United States Department of War, Button Capital, and are 5 of 9 investors who have invested in Flow Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process